Treasury Chief Rachel Reeves Aims for Focused Action on Household Expenses in Forthcoming Financial Plan

Treasury head Rachel Reeves has announced she is preparing "specific steps to deal with cost of living issues" in next month's financial statement.

During an interview with media outlets, she emphasized that reducing inflation is a joint duty of both the government and the central bank.

The UK's inflation rate is projected to be the most elevated among the G7 advanced economies this calendar year and next.

Potential Energy Bill Measures

Sources suggest the government could intervene to reduce utility costs, such as by cutting the present 5% level of value-added tax applied on energy.

Another possibility is to lower some of the policy costs currently included in household expenses.

Budgetary Limitations and Analyst Expectations

The government will receive the latest assessment from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will show how much room there is for these measures.

The view from the majority of analysts is that the Chancellor will have to declare tax increases or expenditure reductions in order to meet her voluntary fiscal targets.

Previously on Thursday, analysis suggested there was a £22bn shortfall for the Treasury chief to fill, which is at the more modest range of projections.

"It is a collective task between the central bank and the government to further reduce some of the drivers of inflation," Reeves stated to the BBC in the US capital, at the yearly gatherings of the International Monetary Fund and global financial institution.

Tax Pledges and Global Concerns

While much of the attention has been on probable tax increases, the Treasury chief said the latest information from the fiscal watchdog had not altered her commitment to election pledges not to raise tax levels on earnings tax, VAT or social security contributions.

She attributed an "unpredictable world" with increasing international and commercial issues for the fiscal tax moves, probably to be targeted on those "with the broadest shoulders."

Global Economic Disputes

Commenting on worries about the United Kingdom's economic relations with China she said: "The UK's national security invariably are paramount."

Recent declaration by China to tighten trade restrictions on rare earths and other resources that are essential for advanced tech production led American leader the US President to propose an further 100% import tax on imports from the Asian country, raising the prospect of an full-scale trade war between the two largest economies.

The US Treasury Secretary described the Chinese decision "commercial pressure" and "a international production control attempt."

Inquired about accepting the US offer to join its dispute with the Asian nation, the Chancellor said she was "deeply worried" by Chinese measures and urged the Chinese government "to avoid restrictions and limit trade."

She said the action was "harmful for the global economy and generates further challenges."

"I believe there are fields where we should challenge China, but there are also significant chances to sell into China's economy, including financial services and other sectors of the economy. We've got to achieve that equilibrium correct."

The Treasury chief also affirmed she was cooperating with other major economies "on our own essential resources plan, so that we are more independent."

Health Service Medicine Costs and Investment

The Chancellor also acknowledged that the price the National Health Service spends on drugs could increase as a consequence of current negotiations with the US government and its drugs companies, in return for lower tariffs and capital.

Some of the biggest global drug companies have said lately that they are either delaying or scrapping investments in the United Kingdom, with several attributing the insufficient payments they are receiving.

Recently, the government science advisor said the cost the NHS pays for drugs would have to go up to stop firms and pharmaceutical investment departing from the UK.

The Chancellor told media: "It has been observed due to the cost structure, that clinical trials, new drugs have not been available in the United Kingdom in the manner that they are in other EU nations."

"The objective is to make sure that individuals getting care from the NHS are able to obtain the finest life-saving medicines in the world. And so we are looking at all of that, and... looking to obtain more capital into the UK."